메뉴 건너뛰기




Volumn 61, Issue 6, 2001, Pages 685-694

Enzymatic activation of a new antitumour drug, 5-diethylaminoethylamino-8-hydroxyimidazoacridinone, C-1311, observed after its intercalation into DNA

Author keywords

Antitumour compounds; DNA intercalation; Enzymatic activation; Imidazoacridinone derivatives; Metabolic activation; Mode of antitumour action

Indexed keywords

DNA; HORSERADISH PEROXIDASE; HYDROGEN PEROXIDE; IMIDACRINE;

EID: 0035868981     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00527-5     Document Type: Article
Times cited : (35)

References (17)
  • 7
    • 0029825583 scopus 로고    scopus 로고
    • Cell killing by the novel imidazoacridinone antineoplastic agent, C-1311, is inhibited at high concentrations coincident with dose-differentiated cell cycle perturbation
    • (1996) Br J Cancer , vol.74 , pp. 1359-1361
    • Wheatley, D.N.1    Lamb, J.2
  • 11
    • 0001094908 scopus 로고    scopus 로고
    • Characterisation of covalent binding to DNA of antitumor imidazoacridinone C-1311, after metabolic activation
    • (1998) Ann Oncol , vol.9 , Issue.SUPPL. 1 , pp. 137
    • Dziegielewski, J.1    Konopa, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.